Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2s,5s)-5-methyl-3,6-dioxo-2-piperazineacetic Acid
2. Ampion
3. Ap-013
4. Ap013
5. Da-dkp
1. Ampion
2. 110954-19-3
3. Da-dkp
4. R9chm391d5
5. 2-((2s,5s)-5-methyl-3,6-dioxopiperazin-2-yl)acetic Acid
6. 2-[(2s,5s)-5-methyl-3,6-dioxopiperazin-2-yl]acetic Acid
7. 2-piperazineacetic Acid, 5-methyl-3,6-dioxo-, (2s,5s)-
8. Unii-r9chm391d5
9. Chembl4297349
10. Zinc33961611
11. Akos026716132
12. Db14940
13. Hy-107091
14. Cs-0027308
15. Q27288007
16. F2147-2995
17. 2-piperazineaceticacid,5-methyl-3,6-dioxo-,(2s,5s)-(9ci)
18. [(2s,5s)-5-methyl-3,6-dioxopiperazin-2-yl]acetic Acid
19. 1879938-60-9
| Molecular Weight | 186.17 g/mol |
|---|---|
| Molecular Formula | C7H10N2O4 |
| XLogP3 | -1.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 186.06405680 g/mol |
| Monoisotopic Mass | 186.06405680 g/mol |
| Topological Polar Surface Area | 95.5 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 263 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Aspartyl-alanyl-diketopiperazine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Aspartyl-alanyl-diketopiperazine, including repackagers and relabelers. The FDA regulates Aspartyl-alanyl-diketopiperazine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Aspartyl-alanyl-diketopiperazine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Aspartyl-alanyl-diketopiperazine supplier is an individual or a company that provides Aspartyl-alanyl-diketopiperazine active pharmaceutical ingredient (API) or Aspartyl-alanyl-diketopiperazine finished formulations upon request. The Aspartyl-alanyl-diketopiperazine suppliers may include Aspartyl-alanyl-diketopiperazine API manufacturers, exporters, distributors and traders.
Aspartyl-alanyl-diketopiperazine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Aspartyl-alanyl-diketopiperazine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Aspartyl-alanyl-diketopiperazine GMP manufacturer or Aspartyl-alanyl-diketopiperazine GMP API supplier for your needs.
A Aspartyl-alanyl-diketopiperazine CoA (Certificate of Analysis) is a formal document that attests to Aspartyl-alanyl-diketopiperazine's compliance with Aspartyl-alanyl-diketopiperazine specifications and serves as a tool for batch-level quality control.
Aspartyl-alanyl-diketopiperazine CoA mostly includes findings from lab analyses of a specific batch. For each Aspartyl-alanyl-diketopiperazine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Aspartyl-alanyl-diketopiperazine may be tested according to a variety of international standards, such as European Pharmacopoeia (Aspartyl-alanyl-diketopiperazine EP), Aspartyl-alanyl-diketopiperazine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Aspartyl-alanyl-diketopiperazine USP).
LOOKING FOR A SUPPLIER?
